MediWound (MDWD) Competitors

MediWound (NASDAQ:MDWD) and Oculis (NASDAQ:OCS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, risk, earnings, institutional ownership, dividends, analyst recommendations, valuation and profitability.

Which has higher earnings and valuation, MDWD or OCS?

MediWound has higher revenue and earnings than Oculis. Oculis is trading at a lower price-to-earnings ratio than MediWound, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MediWound	$20.22M	9.41	-$30.22M	-$2.64	-6.67
Oculis	$780K	999.14	-$97.43M	-$2.64	-6.76

Is MDWD or OCS more profitable?

MediWound has a net margin of -142.18% compared to Oculis' net margin of -13,958.12%. MediWound's return on equity of -96.71% beat Oculis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MediWound	-142.18%	-96.71%	-39.73%
Oculis	-13,958.12%	-99.12%	-72.89%

Do institutionals and insiders believe in MDWD or OCS?

46.8% of MediWound shares are held by institutional investors. Comparatively, 22.3% of Oculis shares are held by institutional investors. 9.2% of MediWound shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Do analysts rate MDWD or OCS?

MediWound currently has a consensus price target of $32.25, suggesting a potential upside of 83.24%. Oculis has a consensus price target of $35.67, suggesting a potential upside of 99.81%. Given Oculis' stronger consensus rating and higher probable upside, analysts plainly believe Oculis is more favorable than MediWound.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MediWound	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80
Oculis	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has more risk & volatility, MDWD or OCS?

MediWound has a beta of 0.21, indicating that its stock price is 79% less volatile than the S&P 500. Comparatively, Oculis has a beta of 0.27, indicating that its stock price is 73% less volatile than the S&P 500.

Does the media favor MDWD or OCS?

In the previous week, Oculis had 7 more articles in the media than MediWound. MarketBeat recorded 14 mentions for Oculis and 7 mentions for MediWound. Oculis' average media sentiment score of 0.22 beat MediWound's score of -0.37 indicating that Oculis is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MediWound	0 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Oculis	4 Very Positive mention(s)	0 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

MediWound beats Oculis on 9 of the 15 factors compared between the two stocks.